Sangamo BioSciences - Precio De Mercado

SGMO

11.24

Cambio Diario:

0%

Anual:

2.27%

Precio Día Año
Alnylam Pharmaceuticals 165.02 1.76 1.08% 31.61%
Amgen 242.77 -1.87 -0.76% 11.41%
Avrobio Inc 9.54 -0.09 -0.93% -56.52%
Bayer 53.56 0.09 0.17% -17.92%
BioCryst Pharmaceuticals 16.71 -0.50 -2.91% 289.51%
Biogen 396.64 -18.07 -4.36% 42.03%
Bluebird Bio 34.10 0.21 0.62% -46.66%
BioMarin Pharmaceutical 82.07 -1.60 -1.91% -22.37%
Five Prime Therapeutics 38.00 0.01 0.03% 1,339.39%
Gilead Sciences 68.77 -0.52 -0.75% -6.05%
GlaxoSmithKline 1,408.80 5.40 0.38% -11.99%
Intercept Pharmaceuticals 20.50 0.06 0.28% -72.73%
Ionis Pharmaceuticals 37.93 -0.28 -0.73% -35.00%
Johnson & Johnson 164.96 -2.12 -1.27% 16.05%
Karyopharm Therapeutics 10.32 -0.23 -2.18% -38.20%
Merck & Co 76.27 0.13 0.17% -0.04%
Novartis 83.77 0.45 0.54% 3.65%
Omeros 15.81 -0.01 -0.06% 8.03%
Pfizer 40.01 -0.53 -1.30% 18.55%
Ultragenyx Pharmaceutical 99.36 2.35 2.37% 45.99%
Regulus Therapeutics 1.06 -0.01 -0.95% 12.75%
Roche Holding 341.75 -0.25 -0.07% 4.26%
Sanofi 88.77 -0.13 -0.15% -0.47%
Sangamo BioSciences 11.24 0 0% 2.27%
Sarepta Therapeutics 75.00 -0.75 -0.86% -52.79%
Vertex Pharmaceuticals 194.71 -23.75 -10.96% -27.50%
Acceleron Pharma 133.44 2.57 1.96% 39.93%
Ziopharm Oncology 2.84 -0.02 -0.69% -8.53%

Precio Día Año
NASDAQ 14069 49.09 0.35% 46.73%
US2000 2335 24.40 1.06% 68.32%

SGMO:US
Bienes
Efectivo Y Equivalentes
Activos Circulantes
Pasivo Circulante
DEUDA
EBIT
EBITDA
Eps Ganancias Por Acción
Capital Y Las Reservas
Capital De Préstamo
Capitalización De Mercado
Lngresos Netos
Los Gastos De Explotación
Beneficio Operativo
Capital Social Ordinario
Beneficio Antes De Impuestos
Ingresos Por Ventas
Gastos De Venta Y Administración
Valores
Acreedores Comerciales
Deudores Comerciales